发明申请
- 专利标题： DNA-PK INHIBITORS
-
申请号： US16372080申请日： 2019-04-01
-
公开(公告)号： US20190290654A1公开(公告)日： 2019-09-26
- 发明人: John Patrick Maxwell , Paul S. Charifson , Qing Tang , Steven M. Ronkin , Katrina Lee Jackson , Albert Charles Pierce , David J. Lauffer , Pan Li , Simon Giroux , Jinwang Xu , Kevin Michael Cottrell , Mark A. Morris , Nathan D. Waal , John J. Court , Wenxin Gu , Hongbo Deng
- 申请人： Vertex Pharmaceuticals Incorporated
- 申请人地址： US MA Boston
- 专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人地址： US MA Boston
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D403/12 ; C07D241/42 ; A61K31/506 ; C07D513/04 ; C07D498/08 ; C07D491/048 ; C07D487/04 ; C07D475/00 ; C07D473/40 ; C07D471/04 ; C07D417/12 ; C07D413/12 ; C07D405/14 ; C07D405/12 ; C07D403/14 ; C07D401/14 ; C07D241/40 ; C07D491/08 ; C07D271/12 ; C07D401/12 ; C07D413/14 ; C07D491/056 ; C07D491/052 ; C07D241/44 ; C07D413/04 ; A61K31/5386
摘要：
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
公开/授权文献
- US10973830B2 Substituted quinoxaline DNA-PK inhibitors 公开/授权日：2021-04-13